SO
FNCH

STRS Ohio’s Finch Therapeutics Group, Inc. Common Stock FNCH Stock Holding History

STRS Ohio’s Portfolio FNCH Stock Details FNCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-60
Closed -$9K – 2368
2022
Q1 		$9K Hold
60
– – ﹤0.01% 2099
2021
Q4 		$17K Hold
60
– – ﹤0.01% 2130
2021
Q3 		$23K Hold
60
– – ﹤0.01% 2179
2021
Q2 		$25K Buy
+60
New +$26K ﹤0.01% 2168

Other funds holding FNCH

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
AMC
Avenir Management Company New York $43.8M AUM 101.91% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
LSAG
Lake Street Advisors Group Portsmouth, New Hampshire $2.17B AUM 16.99% 1-Year Est. Return
TA
TRB Advisors New York $146M AUM 3.71% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

STRS Ohio's FNCH Position: Q2 2022 in Review

STRS Ohio sold out of Finch Therapeutics Group, Inc. Common Stock (FNCH) in Q2 2022, closing a stake of 60 shares — an estimated $9K sold.

STRS Ohio first reported a position in FNCH in Q2 2021 and held it in 4 quarters. The position peaked at $25K in Q2 2021. 46 funds tracked by Wall St. Rank hold FNCH as of Q2 2022.

  • STRS Ohio reported no remaining Finch Therapeutics Group, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • STRS Ohio sold 60 Finch Therapeutics Group, Inc. Common Stock shares in Q2 2022, an estimated $9K.
  • STRS Ohio first reported a position in Finch Therapeutics Group, Inc. Common Stock in Q2 2021 and held it in 4 quarters.
  • STRS Ohio's Finch Therapeutics Group, Inc. Common Stock position peaked at $25K in Q2 2021.
  • 46 funds tracked by Wall St. Rank held Finch Therapeutics Group, Inc. Common Stock as of Q2 2022.

Based on STRS Ohio's 13F filing for Q2 2022, filed 25 Jul 2022.